Injectable Drug Compatibility News

We added new stability information to these existing drug monographs:  BUPRENORPHINE HYDROCHLORIDE, CEFUROXIME SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, ERAVACYCLINE, and FUROSEMIDE. In addition, new compatibility information is reported for ERAVACYCLINE with 51 other drugs. 

Y-Site Compatibility Wall Charts Updated for 2020 King Guide Y-Site Compatibility Wall Charts include 123 IV drugs in 4 infusion fluids. Critical Care Admixtures We added 'Oxytocin' Updated with compatibility data published in the King Guide to Parenteral Admixtures for 2019 Available in English or French Laminated 27" x 27" poster Chemotherapy Admixtures Updated with compatibility data published in the King Guide to Parenteral Admixtures for 2019 Available in English Laminated 27" x 27" poster  

Our Winter 2019 update includes 8 new drugs, new stability information for 9 drugs, and new compatibility information for 14 drugs.

In this update we added a new drug monograph for DALBAVANCIN. We added new stability information to the existing drug monographs for AMIODARONE HYDROCHLORIDE, CARBOPLATIN, CEFAZOLIN SODIUM, CEFTAZIDIME, INFLIXIMAB, MEROPENEM, METHOTRIMEPRAZINE HYDROCHLORIDE, PIPERACILLIN and TAZOBACTAM, AND SODIUM THIOSULFATE. In addition, new compatibility information is reported for these drugs:  ACETAMINOPHEN, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BLINATUMOMAB, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE PHOSPHATE, FENTANYL CITRATE, FOSPHENYTOIN SODIUM, FUROSEMIDE, HALOPERIDOL LACTATE, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, KETOPROFEN, LIDOCAINE HYDROCHLORIDE, MAGNESIUM SULFATE, METRONIDAZOLE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, RASBURICASE, SUGAMMADEX, TOTAL PARENTERAL NUTRITION SOLUTIONS, VINCRISTINE SULFATE, and VORICONAZOLE.

New and updated injectable drug compatibility and stability information added to the King Guide for Summer 2019.